Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria
- PMID: 11703336
- DOI: 10.1046/j.1365-2141.2001.03113.x
Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria
Abstract
Paroxysmal nocturnal haemoglobinuria (PNH) is characterized by the expansion of a haematopoietic stem cell clone with a PIG-A mutation (the PNH clone) in an environment in which normal stem cells are lost or failing: it has been hypothesized that this abnormal marrow environment provides a relative advantage to the PNH clone. In patients with PNH, generally, the karyotype of bone marrow cells has been reported to be normal, unlike in myelodysplastic syndrome (MDS), another clonal condition in which cytogenetic abnormalities are regarded as diagnostic. In a retrospective review of 46 patients with a PNH clone, we found a karyotypic abnormality in 11 (24%). Upon follow-up, the proportion of cells with abnormal karyotype decreased significantly in seven of these 11 patients. Abnormal morphological bone marrow features reminiscent of MDS were common in PNH, regardless of the karyotype. However, none of our patients developed excess blasts or leukaemia. We conclude that in patients with PNH cytogenetically abnormal clones are not necessarily malignant and may not be predictive of evolution to leukaemia.
Similar articles
-
Paroxysmal nocturnal hemoglobinuria and myelodysplastic syndrome: Disappearance of cytogenetic abnormalities.Cancer Genet. 2021 Jan;250-251:1-5. doi: 10.1016/j.cancergen.2020.11.001. Epub 2020 Nov 6. Cancer Genet. 2021. PMID: 33188967
-
Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.Int J Hematol. 2000 Aug;72(2):206-9. Int J Hematol. 2000. PMID: 11039670
-
Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes.Br J Haematol. 1998 Jul;102(2):465-74. doi: 10.1046/j.1365-2141.1998.00794.x. Br J Haematol. 1998. PMID: 9695961
-
A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.Hematology. 2002 Aug;7(4):211-27. doi: 10.1080/1024533021000024094. Hematology. 2002. PMID: 14972783 Review.
-
Clonality of the stem cell compartment during evolution of myelodysplastic syndromes and other bone marrow failure syndromes.Leukemia. 2007 Aug;21(8):1648-57. doi: 10.1038/sj.leu.2404757. Epub 2007 Jun 7. Leukemia. 2007. PMID: 17554386 Review.
Cited by
-
Last marrow standing: bone marrow transplantation for acquired bone marrow failure conditions.Curr Hematol Malig Rep. 2012 Dec;7(4):292-9. doi: 10.1007/s11899-012-0138-x. Curr Hematol Malig Rep. 2012. PMID: 23065408 Free PMC article. Review.
-
Complement and inflammasome overactivation mediates paroxysmal nocturnal hemoglobinuria with autoinflammation.J Clin Invest. 2019 Dec 2;129(12):5123-5136. doi: 10.1172/JCI123501. J Clin Invest. 2019. PMID: 31430258 Free PMC article.
-
Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.Blood. 2020 Jul 2;136(1):36-49. doi: 10.1182/blood.2019000940. Blood. 2020. PMID: 32430502 Free PMC article.
-
Myelodysplastic syndromes.Nat Rev Dis Primers. 2022 Nov 17;8(1):74. doi: 10.1038/s41572-022-00402-5. Nat Rev Dis Primers. 2022. PMID: 36396662 Review.
-
Paroxysmal nocturnal haemoglobinuria.Nat Rev Dis Primers. 2017 May 18;3:17028. doi: 10.1038/nrdp.2017.28. Nat Rev Dis Primers. 2017. PMID: 28516949 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous